NCT04389853

Brief Summary

The prevalence of nephrolithiasis is increasing over the last two decades, and kidney stones is a recurrent disorder, with lifetime recurrence risks reported to be as high as 50%. One of the most challenging stones is the lower pole (LP) nephrolithiasis. The standard management of lower pole stones (LPS), is still controversial especially for stones smaller than 20 mm, with retrograde intrarenal surgery (RIRS) and mini-PCNL (miniperc) both demonstrated to be safe and effective methods for treating LPS with a diameter of 1-2 cm. Selecting the optimal modality for treating renal calculi is challenging, as both techniques may be associated with different patient benefits and risk profiles. Despite the evolution of mini-PCNL and fURS techniques into clinical practice, there is a lack of comparative clinical data assessing SFRs and complication rates. To the investigators' knowledge, no previous studies have addressed the outcome of ambulatory tubeless miniperc as a same day procedure, which this study will look to assess. The investigators are planning to discharge all participants home the night of surgery, without admission or insertion of nephrostomy tube. This will decrease the morbidity of miniperc and encourage head-to-head comparison with fURS in a prospective randomized protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 15, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

October 5, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

3.6 years

First QC Date

May 5, 2020

Last Update Submit

August 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Stone-free status

    Operation success will be evaluated with a non-contrast computed tomography (CT) scan on the first post-operative day, as per standard of care. Presence or absence of kidney stones will be confirmed via CT scan

    1-day

  • Stone-free status

    Operation success will be re-evaluated with a non-contrast computed tomography (CT) scan at 4-weeks post-operation, as per standard of care. Presence or absence of kidney stones will be confirmed via CT scan

    4-weeks post-op

Secondary Outcomes (5)

  • To compare safety measures

    4 weeks

  • To compare stone free status of single use vs reusable fURS

    1-day post-op

  • To compare stone free status of single use vs reusable fURS

    4-weeks post-op

  • Assess the postoperative pain between both techniques

    1-day post-op

  • Assess the postoperative pain between both techniques

    4-weeks post-op

Study Arms (2)

Flexible ureteroscopy (fURS)

ACTIVE COMPARATOR

Retrograde intrarenal surgery (RIRS) has gained much popularity especially when the role of SWL, in management of LPS, has been significantly diminished in the few last years5. RIRS is dependent mainly on flexible ureteroscopy (fURS). fURS increases the quality and performance of upper urinary tract exploration, allowing for the treatment of the majority of stones at all sites. Moreover, it is associated with no risk of renal parenchymal injuries and a very low risk of bleeding.

Procedure: Flexible ureteroscopy

Mini-percutaneous nephrolithotomy (mini-PCNL)

ACTIVE COMPARATOR

PCNL has regained popularity thanks to the possibility of using reduced calibers and modern technology, which has reduced the complications without compromising the stone clearance, and more efficient intracorporeal lithotripter modalities. However, PCNL is still a challenging surgical technique and can be associated with significant complications that may compromise its efficacy. In the present time, we have available calibers ranging from 4.8 to 30 French. Many reports advocate that morbidity after PCNL may be reduced by recent modifications, such as mini-PCNL (miniperc). One meta-analysis of mini-PCNL and conventional PCNL demonstrated that mini-PCNL had a greater safety profile with similar stone free rates (SFRs)4

Procedure: Mini-percutaneous nephrolithotomy

Interventions

Retograde intrarenal surgery (RIRS) has gained much popularity especially when the role of SWL, in management of LPS, has been significantly diminished in the few last years5. RIRS is dependent mainly on flexible ureteroscopy (fURS). fURS increases the quality and performance of upper urinary tract exploration, allowing for the treatment of the majority of stones at all sites. Moreover, it is associated with no risk of renal parenchymal injuries and a very low risk of bleeding.

Flexible ureteroscopy (fURS)

PCNL has regained popularity thanks to the possibility of using reduced calibers and modern technology, which has reduced the complications without compromising the stone clearance, and more efficient intracorporeal lithotripter modalities. However, PCNL is still a challenging surgical technique and can be associated with significant complications that may compromise its efficacy. In the present time, we have available calibers ranging from 4.8 to 30 French. Many reports advocate that morbidity after PCNL may be reduced by recent modifications, such as mini-PCNL (miniperc). One meta-analysis of mini-PCNL and conventional PCNL demonstrated that mini-PCNL had a greater safety profile with similar stone free rates (SFRs).

Mini-percutaneous nephrolithotomy (mini-PCNL)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects over 18 years of age at the time of enrollment.
  • Patients referred with single kidney stones of 10-20 mm in its largest diameter, or multiple stones involving a single calyx.
  • Written informed consent to participate in the study
  • Ability to comply with the requirements of the study procedures

You may not qualify if:

  • Congenital anatomic anomalies of the kidney, ureters or bladder.
  • Previous ipsilateral renal surgery within past five years.
  • Patients with ipsilateral distal ureteral stones or stricture.
  • Stone size \> 20 mL or multiple kidney stones in different calyces.
  • Previous SWL treatment for the same stone.
  • Patients presented with a previously inserted ipsilateral ureteral stent.
  • Participants with active urinary tract infection until appropriately treated
  • Uncorrected coagulopathy (anticoagulants or blood thinners which cannot be withheld before surgery).
  • Pregnancy or morbid obesity
  • Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
  • Participants who are uncooperative or cannot follow instructions.
  • Participants who lack the capacity to provide free and informed written consent.
  • Patients with solitary kidney.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thunder Bay Regional Health Sciences Centre/Thunder Bay Regional Health Research Institute

Thunder Bay, Ontario, P7B6V4, Canada

Location

MeSH Terms

Conditions

NephrolithiasisKidney Calculi

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Hazem Elmansy, MD

    Thunder Bay Regional Health Sciences Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Control Study comparing two standard of care treatments.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urology Surgeon

Study Record Dates

First Submitted

May 5, 2020

First Posted

May 15, 2020

Study Start

October 5, 2020

Primary Completion

April 24, 2024

Study Completion

April 24, 2024

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

There are no plans to share participant data with other researchers. Findings may be presented locally, nationally, and internationally at conferences. Any data presented will be de-identified and grouped prior to use, as to protect participant confidentiality.

Locations